Special 301 submission calls for a level playing field for American innovators

The Office of the U.S. Trade Representative (USTR) ’s 2019Special 301 Report– scheduled to be released this spring – brings critical attention to overseas intellectual property (IP) and market access challenges that harm American innovators, patients and workers. In our2019 Special 301submission, PhRMA encourages the Administration to take a tough stance in addressing the negative, unfair practices of certain countries.

Source: The Catalyst - March 13, 2019 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Patents Intellectual Property 301 Report trade Source Type: news